Unaltered T cell responses to common antigens in individuals with Parkinson’s disease

Background and Objectives Parkinson’s disease (PD) is associated with a heightened inflammatory state, including activated T cells. However, it is unclear whether these PD T cell responses are antigen specific or more indicative of generalized hyperresponsiveness. Our objective was to measure and compare antigen-specific T cell responses directed towards antigens derived from commonly encountered human pathogens/vaccines in patients with PD and age-matched healthy controls (HC). Methods Peripheral blood mononuclear cells (PBMCs) from 20 PD patients and 19 age-matched HCs were screened. Antigen specific T cell responses were measured by flow cytometry using a combination of the activation induced marker (AIM) assay and intracellular cytokine staining. Results Here we show that both PD patients and HCs show similar T cell activation levels to several antigens derived from commonly encountered human pathogens/vaccines in the general population. Similarly, we also observed no difference between HC and PD in the levels of CD4 and CD8 T cell derived cytokines produced in response to any of the common antigens tested. These antigens encompassed both viral (coronavirus, rhinovirus, respiratory syncytial virus, influenza, cytomegalovirus) and bacterial (pertussis, tetanus) targets. Conclusions These results suggest the T cell dysfunction observed in PD may not extend itself to abnormal responses to commonly encountered or vaccine-target antigens. Our study supports the notion that the targets of inflammatory T cell responses in PD may be more directed towards autoantigens like α-synuclein (α-syn) rather than common foreign antigens.

[1]  S. Elledge,et al.  Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis , 2022, Science.

[2]  Mark M. Davis,et al.  CD4+ T cells contribute to neurodegeneration in Lewy body dementia , 2021, Science.

[3]  Wei Yang,et al.  Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson Disease , 2021, Neurology: Neuroimmunology & Neuroinflammation.

[4]  M. Mittelbrunn,et al.  The role of T cells in age-related diseases , 2021, Nature Reviews Immunology.

[5]  Sonja W. Scholz,et al.  Challenges in the diagnosis of Parkinson's disease , 2021, The Lancet Neurology.

[6]  Samantha M. Carlisle,et al.  Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease , 2021, NPJ Parkinson's disease.

[7]  A. Sette,et al.  Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers , 2021, The Journal of infectious diseases.

[8]  Bjoern Peters,et al.  Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection , 2021, Science.

[9]  A. Sette,et al.  Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19 , 2020, Cell.

[10]  S. Mallal,et al.  Identification and Characterization of CD4+ T Cell Epitopes after Shingrix Vaccination , 2020, Journal of Virology.

[11]  J. Greenbaum,et al.  Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals , 2020, Cell.

[12]  Sandeep Kumar Dhanda,et al.  Development and Validation of a Bordetella pertussis Whole-Genome Screening Strategy , 2020, Journal of immunology research.

[13]  R. Scheuermann,et al.  A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2 , 2020, Cell Host & Microbe.

[14]  Zachary D. Wallen,et al.  Innate and adaptive immune responses in Parkinson's disease. , 2020, Progress in brain research.

[15]  D. Berg,et al.  Alterations in Blood Monocyte Functions in Parkinson's Disease , 2019, Movement disorders : official journal of the Movement Disorder Society.

[16]  R. Scheuermann,et al.  A survey of known immune epitopes in the enteroviruses strains associated with acute flaccid myelitis. , 2019, Human immunology.

[17]  P. Iwanowski,et al.  Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications , 2019, Front. Neurol..

[18]  Morten Nielsen,et al.  IEDB-AR: immune epitope database—analysis resource in 2019 , 2019, Nucleic Acids Res..

[19]  S. Kügler,et al.  β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration , 2019, Nature.

[20]  M. Dubinsky,et al.  Anti–Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease , 2018, JAMA neurology.

[21]  Gene W. Yeo,et al.  Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson's Disease. , 2018, Cell stem cell.

[22]  D. Kaufmann,et al.  Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells , 2017, PloS one.

[23]  S. Mallal,et al.  T cells of Parkinson’s disease patients recognize α–synuclein peptides , 2017, Nature.

[24]  Manoj Kumar,et al.  INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.

[25]  S. Mallal,et al.  Definition of Human Epitopes Recognized in Tetanus Toxoid and Development of an Assay Strategy to Detect Ex Vivo Tetanus CD4+ T Cell Responses , 2017, PloS one.

[26]  Alessandro Sette,et al.  A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood , 2016, The Journal of Immunology.

[27]  J. Woulfe,et al.  Human serum antibodies against EBV latent membrane protein 1 cross-react with α-synuclein , 2016, Neurology: Neuroimmunology & Neuroinflammation.

[28]  Bjoern Peters,et al.  Automatic Generation of Validated Specific Epitope Sets , 2015, Journal of immunology research.

[29]  M. Okun,et al.  The Demise of Poskanzer and Schwab's Influenza Theory on the Pathogenesis of Parkinson's Disease , 2013, Parkinson's disease.

[30]  Kosloski,et al.  CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease , 2012, Journal of Neuroimmune Pharmacology.

[31]  K. Teschke,et al.  Association of Parkinson's disease with infections and occupational exposure to possible vectors , 2012, Movement disorders : official journal of the Movement Disorder Society.

[32]  A. Espay,et al.  Postencephalitic parkinsonism and basal ganglia necrosis due to Epstein-Barr virus infection , 2011, Neurology.

[33]  S. Toovey,et al.  Parkinson’s disease or Parkinson symptoms following seasonal influenza , 2011, Influenza and other respiratory viruses.

[34]  E. Hirsch,et al.  Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. , 2008, The Journal of clinical investigation.

[35]  Houeto Jean-Luc [Parkinson's disease]. , 2022, La Revue du praticien.

[36]  S. Ambrosio,et al.  Lymphocyte populations in Parkinson’s disease and in rat models of parkinsonism , 2001, Journal of Neuroimmunology.

[37]  J. Fleming,et al.  Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[38]  P. Mcgeer,et al.  Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.

[39]  P. Fishman,et al.  Infection of the basal ganglia by a murine coronavirus. , 1985, Science.

[40]  R. Schwab,et al.  COHORT ANALYSIS OF PARKINSON'S SYNDROME: EVIDENCE FOR A SINGLE ETIOLOGY RELATED TO SUBCLINICAL INFECTION ABOUT 1920. , 1963, Journal of chronic diseases.